drugset / Trial / NCT06044974
Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.
RandomizedParallel-groupSingle-blindTreatment
Summary
A clinical trial comparing the potential effect of 2 different modalities (Nd-YAG Laser Versus Epidermal growth factor injection) on pain reduction in patients suffering from myogenic tempromandibular disorder.
Timeline
- Start
- 2023-01-21
- Primary completion
- 2023-08-10
- Completion
- 2024-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NEPIDERMIN | Protein / enzyme biologic | 0.1 ml | — |